Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Asia-Pacific Insulin Infusion Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... - 2027). People with Covid-19 had a statistically greater incidence of type 2 diabetes and other kinds of diabetes in the Asia-Pacific region. Individuals with no history of diabetes who recovered from SARS-CoV-2 infections have ... Read More
-
Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 'Insulin Like Growth Factor I - Drugs In Development, 2022'; Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) pipeline Target constitutes close to 10 molecules. Out of which approximately 7 ... Read More
-
Diabetic Foot Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Diabetic Foot Ulcers (Metabolic Disorders) pipeline landscape. Diabetic foot ulcers are sores that occur on the feet of people with Type 1 Diabetes and Type 2 Diabetes. Symptoms ... Read More
-
Pet Diabetes Care Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... the pet diabetes market significantly. The COVID-19 pandemic imposed hurdles and concerns in the global pet animal health sector, including decreased marketing and sales efforts, reduced people visiting veterinary clinics, cancellation of regular pet check-ups, ... Read More
-
MIDDLE-EAST AND AFRICA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... forecast period 2022-2027. The market is estimated to reach more than USD 5.7 billion by 2027. The COVID-19 pandemic positively impacted the Middle-East and African diabetes drugs market. Diabetes and uncontrolled hyperglycemia are risk factors ... Read More
-
THAILAND DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2027. The healthcare system was significantly disturbed and pressured during each phase of rapid COVID-19 infection. Several countries, notably the Thai government, have introduced home isolation or a home quarantine program to avert healthcare collapse ... Read More
-
INDIA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... COVID-19 infections, which began around two years ago, have contributed to a nearly 25% increase. With Over 80 million diabetics, India is commonly referred to be the diabetes capital. COVID, a viral infection that generates ... Read More
-
EUROPE INSULIN DRUGS AND GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONIST MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... to register a CAGR greater than 4% over the forecast period, 2022-2027. The COVID-19 epidemic has significantly affected the market for insulin drugs and devices. Patients with type-1 diabetes are more affected by COVID-19. Since ... Read More
-
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Diabetic Retinopathy (Metabolic Disorders) pipeline landscape. Diabetic retinopathy is a complication of diabetes that affects the eyes. Diabetic retinopathy symptoms may include spots or dark strings floating in vision (floaters), ... Read More
-
NORTH AMERICA DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... period, 2022-2027. In North America, till April 2022, the United States is having the highest COVID cases with 82 million, the country also registered the highest death rate. According to the Diabetes Voice article published ... Read More
-
AUSTRALIA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... epidemic boosted the expansion of the Australia Diabetes Care Drugs Market. Diabetes patients infected with COVID-19 may have high blood glucose levels, irregular glucose variability, and diabetic complications. According to the Australian Government Department of ... Read More
-
JAPAN DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... COVID-19 pandemic has had a substantial impact on the diabetes drugs market. The prevalence of diabetes in people hospitalized with COVID-19 infection and the recognition that improved glycemic control might improve outcomes and reduce the ... Read More
-
Asia-Pacific Diabetes Care Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... period (2022 - 2027) and is estimated to reach around USD 25 billion by 2027. Japan holds the highest market share in the Asia-Pacific Diabetes Care Devices Market and is expected to register the highest ... Read More
-
MEXICO DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... more than USD 600 million by 2027, registering a CAGR of more than 6.5% during the forecast period 2022- 2027. The COVID-19 pandemic has had a notable impact on the diabetes care devices market. Diabetes ... Read More
-
MIDDLE EAST AND AFRICA DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... more than 4% during the forecast period (2022-2027). The market is estimated to reach a value of more than USD 2.7 billion by 2027. The COVID-19 pandemic positively impacted the Middle East and Africa diabetes ... Read More
-
UNITED KINGDOM (UK) DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... than 3%. The COVID-19 pandemic has had a substantial impact on the United Kingdom’s diabetes drugs market. According to The British Diabetic Association, “The pandemic has had and continues to have, a huge impact on ... Read More
-
Asia-Pacific Alpha-Glucosidase Inhibitors Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)
... had a statistically greater incidence of type 2 diabetes and other kinds of diabetes in the Asia-Pacific region. Individuals with no history of diabetes who recovered from SARS-CoV-2 infections have been reported to develop insulin ... Read More
-
EUROPE DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... pandemic has substantially impacted the European Diabetes Drugs Market. People with diabetes have a weak immune system so, with COVID-19, the immune system gets weaker very fast. People with diabetes have more chances to get ... Read More
-
UNITED STATES DIABETES DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... Since the start of the epidemic, the United States has recorded 79 million cases of COVID-19. Over 960,000 people have died in the United States because of COVID-19. The average number of new COVID-19 cases ... Read More
-
Asia-Pacific Insulin Pens Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... market is estimated to reach a value of more than USD 19 billion by 2027. The COVID-19 pandemic positively impacted the Asia-Pacific Insulin Pens Market. Patients with diabetes, infected with COVID-19 may experience elevated blood ... Read More
-
ITALY DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Italy was the first country in Europe affected by COVID-19. Italy is among the countries with ... Read More
-
Saudi Arabia Diabetes Care Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... period (2022-2027). In Riyadh, hospitalized COVID-19 patients had a significant frequency of diabetes mellitus. Even though people with diabetes have a higher mortality rate than people without the disease, other factors, including advanced age, congestive ... Read More
-
RUSSIA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Russia has the ninth-highest number of confirmed cases in the world affected by COVID-19. Most people ... Read More
-
SOUTH AFRICA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. The market is estimated to reach a value of more than USD 380 million by 2027. The COVID-19 pandemic positively impacted the Diabetes Drugs market growth in South Africa. Patients with diabetes, infected with ... Read More
-
COMBINATION ANTI-DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... market is estimated to reach a value of more than USD 8 billion by 2027. Diabetes mellitus increases the risk of viral infections, especially during the period of poor glycemic control. Emerging evidence suggests that ... Read More
Research Assistance
